Showing results (241-250 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|July 13, 2015
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinomaJia-Yuan Huang, Kai Zhang, Dong-Qin Chen, et al.
Oncotarget|June 24, 2015
P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transitionYanhong Zhang, Ashley Young, Jin Zhang, et al.
Oncotarget|June 26, 2015
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levelsByungho Lim, Jihyeob Mun, Jeong-Hwan Kim, et al.
Oncotarget|June 26, 2015
The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesisFrancesca Grasso, Serena Di Meo, Gabriele De Luca, et al.
Oncotarget|June 26, 2015
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisGui-Qi Zhu, Sha Huang, Gui-Qian Huang, et al.
Oncotarget|June 28, 2015
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21Simona Taverna, Marco Giallombardo, Marzia Pucci, et al.
Oncotarget|July 6, 2015
Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycyclineMary Pulvino, Luojing Chen, David Oleksyn, et al.
Oncotarget|July 6, 2015
VGF expression by T lymphocytes in patients with Alzheimer's diseaseStefan Busse, Johann Steiner, Sarah Glorius, et al.
Oncotarget|July 6, 2015
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trialsRuiqin Mai, Songxia Zhou, Weixiang Zhong, et al.
Oncotarget|July 6, 2015
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastomaMohamed Ali Mosrati, Annika Malmström, Malgorzata Lysiak, et al.
Pageof 2,516